# US 2021/0330728 A1 · Methods of Clinical Treatment of a Mammal Experiencing a Viral Respiratory Infection and/or Inflammation Resulting from a Viral Respiratory Infection Using Botanical Infusion

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0330728 A1
- Document ID: US20210330728A1
- Status: Published application
- Kind: A1
- Application number: 17/237,145
- Filed: 2021-04-22
- Published: 2021-10-28
- Earliest claimed: 2020-04-22
- Inventors: Jasmine Gardner
- Web page: https://patentgrep.com/patent/US20210330728A1

## CPC

- A61K 36/61: Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
- A61K 9/0053: {Mouth and digestive tract, i.e. intraoral and peroral administration}
- A61K 35/644: Beeswax; Propolis; Royal jelly; Honey
- A61K 36/481: Astragalus (milkvetch)
- A61K 36/484: Glycyrrhiza (licorice)
- A61K 36/534: Mentha (mint)
- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A61P 11/00: Drugs for disorders of the respiratory system
- A61K 2236/00: Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K 2236/15: involving mechanical treatment, e.g. chopping up, cutting or grinding
- A61K 2236/17: involving drying, e.g. sun-drying or wilting
- A61K 2236/331: using water, e.g. cold water, infusion, tea, steam distillation or decoction
- A61K 2236/333: using mixed solvents, e.g. 70% EtOH
- A61K 2236/37: Extraction at elevated pressure or temperature, e.g. pressurized solvent extraction [PSE], supercritical carbon dioxide extraction or subcritical water extraction
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

As described herein, the invention includes methods for the treatment of a respiratory infection of a coronavirus and/or respiratory inflammation resulting from a coronavirus infection in a mammalian individual. The method includes administering to the individual an effective amount of a water-based infusion prepared by steeping the leaves of eucalyptus globulus Labill, the root of astragalus membranaceus, and the leaves of mentha X piperita in a liquid for a time duration and administering to the patient an effective amount of the infusion. Such administration may be via an oral or an inhalable route. Also included are methods of making a composition for use in the clinical treatment of a COVID-19 (SARS-CoV-2) infection and/or to treat inflammation resulting from an is COVID-19 (SARS-CoV-2) infection comprising steeping in a liquid leaves of eucalyptus globulus Labill, roots of astragalus membranaceus, and the leaves of mentha X piperita, for a duration of time.

## Claims

### Claim 1

A method for the treatment of a respiratory infection of a coronavirus and/or respiratory inflammation resulting from a coronavirus infection in a mammalian individual comprising administering to the individual an effective amount of a water-based infusion prepared by steeping the leaves of eucalyptus globulus Labill, the root of astragalus membranaceus, and the leaves of mentha X piperita in a liquid for a time duration and orally administering to the patient an effective amount of the infusion.

### Claim 2 (depends on 1)

The method of claim 1 wherein the liquid is 100% water.

### Claim 3 (depends on 1)

The method of claim 1 wherein the liquid is a mixture of water and an alcohol.

### Claim 4 (depends on 1)

The method of claim 1 wherein the leaves or root of each of the eucalyptus globulus Labill, astragalus membranaceus, and mentha X piperita are independently in a dried form.

### Claim 5 (depends on 1)

The method of claim 1 wherein the leaves or root of each of the eucalyptus globulus Labill, astragalus membranaceus, and mentha X piperita are independently in a form selected from powdered, pulverized, crumbled, and comminuted.

### Claim 6 (depends on 1)

The method of claim 1 wherein
the eucalyptus globulus Labill is present in amount of about 1 to about 2 tablespoons,
the astragalus membranaceus is present in amount of about 2 to 3.5 tablespoons, and
the mentha X piperita is present in an amount of about 4 to about 6 tablespoons, per about 7 quarts of liquid.

### Claim 7 (depends on 1)

The method of claim 1 wherein
the eucalyptus globulus Labill is present in amount of about 1.5 tablespoons,
the astragalus membranaceus is present in amount of about 2.5 tablespoons, and
the mentha X piperita is present in an amount of about 5.3 tablespoons (⅓ cup), per about 7 quarts of liquid.

### Claim 8 (depends on 1)

The method of claim 1 wherein the time duration of steeping is about 10 minutes to about 10 hours.

### Claim 9 (depends on 1)

The method of claim 1 wherein steeping further comprises application of heat of a temperature of about 90° C. to about 110° C. for at least a portion of the time duration.

### Claim 10 (depends on 9)

The method of claim 9 wherein the heat is applied for about 30 minutes to about 60 minutes.

### Claim 11 (depends on 1)

The method of claim 1 wherein the individual is orally administered the infusion in an amount of about 3 ounces to about 40 ounces.

### Claim 12 (depends on 1)

The method of claim 1 wherein the individual is a human.

### Claim 13 (depends on 1)

The method of claim 1 wherein the infusion further comprises at least one additional ingredient selected from a sweetener, honey, a vitamin, an antioxidant, an expectorant, a topical anesthetic, a cough suppressant, a licorice, an anti-inflammatory compound, an antihistamine, a colorant, an opacifier and a flavorant.

### Claim 14 (depends on 1)

The method according to claim 1, wherein the corona virus is COVID-19 (SARS-CoV-2).

### Claim 15 (depends on 1)

The method of claim 1 wherein the leaves or roots are removed from the infusion prior to the administration of the infusion.

### Claim 16

A method of making a composition for use in the clinical treatment of a COVID-19 (SARS-CoV-2) infection and/or to treat inflammation resulting from an is COVID-19 (SARS-CoV-2) infection comprising steeping in a liquid
leaves of eucalyptus globulus Labill,
roots of astragalus membranaceus,
leaves of mentha X piperita,
for a duration of time.

### Claim 17 (depends on 16)

The method of claim 16 wherein the leaves or root of each of the eucalyptus globulus Labill, astragalus membranaceus, and mentha X piperita are independently in a dried form.

### Claim 18 (depends on 16)

The method of claim 16 wherein the leaves or root of each of the eucalyptus globulus Labill, astragalus membranaceus, and mentha X piperita are independently in a form selected from powdered, pulverized, crumbled, and comminuted.

### Claim 19 (depends on 16)

The method of claim 16 wherein
the eucalyptus globulus Labill is present in amount of about 1 to about 2 tablespoons,
the astragalus membranaceus is present in amount of about 2 to 3.5 tablespoons, and
the mentha X piperita is present in an amount of about 4 to about 6 tablespoons, per about 7 quarts of liquid.

### Claim 20 (depends on 16)

The method of claims 16 wherein
the eucalyptus globulus Labill is present in amount of about 1.5 tablespoons,
the astragalus membranaceus is present in amount of about 2.5 tablespoons, and
the mentha X piperita is present in an amount of about 5.3 tablespoons (⅓ cup), per about 7 quarts of liquid.

### Claim 21 (depends on 16)

The method of claim 16 wherein the time duration of steeping is about 10 minutes to about 10 hours.

### Claim 22 (depends on 16)

The method of claim 16 wherein steeping further comprises application of heat of a temperature of about 90° C. to about 110° C. for at least a portion of the time duration.

### Claim 23 (depends on 22)

The method of claim 22 wherein the heat is applied for about 30 minutes to about 60 minutes.

### Claim 24 (depends on 16)

The method of claim 16 further comprising incorporating into the infusion at least one of a sweetener, honey, a vitamin, an antioxidant, an expectorant, a topical anesthetic, a cough suppressant, a licorice, an anti-inflammatory compound, an antihistamine, a colorant, an opacifier and a flavorant.